TWD 571.0
(-2.89%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 11.87 Million TWD | -41.96% |
2022 | 20.45 Million TWD | -28.4% |
2021 | 28.57 Million TWD | -75.37% |
2020 | 116 Million TWD | 67.51% |
2019 | 69.25 Million TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 9.67 Million TWD | 0.0% |
2024 Q2 | 7.45 Million TWD | 0.0% |
2023 FY | 11.87 Million TWD | -41.96% |
2023 Q3 | 11.87 Million TWD | -26.91% |
2023 Q2 | 16.24 Million TWD | 0.0% |
2023 Q4 | 11.87 Million TWD | 0.0% |
2023 Q1 | - TWD | -100.0% |
2022 Q3 | 20.45 Million TWD | 0.0% |
2022 Q4 | 20.45 Million TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Great Novel Therapeutics Biotech & Medicals | 10.88 Million TWD | -9.126% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 366 Million TWD | 96.756% |
Visgeneer Inc. | 114.17 Million TWD | 89.6% |
Genomics BioSci & Tech. Co.,Ltd. | 222.24 Million TWD | 94.657% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
Sagittarius Life Science Corp | 6.25 Million TWD | -89.862% |
Taiwan Bio Therapeutics Co., Ltd | 250.51 Million TWD | 95.26% |
NaviFUS Corp. | 25.83 Million TWD | 54.043% |
BioGend Therapeutics Co., Ltd. | 9.44 Million TWD | -25.771% |
Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
TaiRx, Inc. | 8.96 Million TWD | -32.389% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Lin BioScience, Inc. | 29.02 Million TWD | 59.092% |
TaiwanJ Pharmaceuticals Co., Ltd. | 472 Thousand TWD | -2415.678% |
Lumosa Therapeutics Co., Ltd. | 8.11 Million TWD | -46.286% |
Anti-Microbial Savior BioteQ Co., Ltd | - TWD | -Infinity% |
BioLASCO Taiwan Co., Ltd. | 51.43 Million TWD | 76.914% |
SYN-TECH Chem. & Pharm. Co., Ltd. | 60.65 Million TWD | 80.423% |
Sunmax Biotechnology Co., Ltd. | 144.77 Million TWD | 91.798% |
RBC Bioscience Corporation | 412.59 Million TWD | 97.122% |
3D Global Biotech Inc. | 4.08 Million TWD | -190.887% |
Level Biotechnology Inc. | 9.88 Million TWD | -20.121% |
Pharmosa Biopharm Inc. | 118.41 Million TWD | 89.973% |
TaiMed Biologics Inc. | 521.7 Million TWD | 97.724% |
Mycenax Biotech Inc. | 569.78 Million TWD | 97.916% |
SynCore Biotechnology Co.,Ltd | - TWD | -Infinity% |
Eusol Biotech Co.,Ltd. | 1.6 Million TWD | -639.352% |
Taiwan Advance Bio-Pharmaceutical Inc. | 86.89 Million TWD | 86.334% |
Feng Chi Biotech Corp. | 8.14 Million TWD | -45.711% |
NeoCore Technology Co., Ltd. | 33.65 Million TWD | 64.715% |
Andros Pharmaceuticals Co.,Ltd | 22.02 Million TWD | 46.086% |
TWi Biotechnology, Inc. | 5.6 Million TWD | -111.922% |
Neith Corporation | 714 Thousand TWD | -1563.025% |
Sunny Pharmtech Inc. | 376.29 Million TWD | 96.845% |
VBI | - TWD | -Infinity% |
Bio Preventive Medicine Corp. | 106.2 Million TWD | 88.819% |
BiOptic Inc. | 85.79 Million TWD | 86.16% |
Ever Supreme Bio Technology Co., Ltd | 503 Thousand TWD | -2260.636% |
GeneReach Biotechnology Corp. | 97.74 Million TWD | 87.852% |
Syngen Biotech Co.,Ltd. | 386.07 Million TWD | 96.924% |
G&E Herbal Biotechnology Co., Ltd. | 1.29 Million TWD | -817.62% |
CHO Pharma, Inc. | - TWD | -Infinity% |
AP Biosciences Inc | 70.42 Million TWD | 83.14% |
Senhwa Biosciences, Inc. | 3.28 Million TWD | -261.241% |
EirGenix Inc. | 436.54 Million TWD | 97.28% |
Enimmune corporation | 1.75 Million TWD | -575.043% |
Lukas Biomedical Inc. | 69.9 Million TWD | 83.014% |
GlycoNex Incorporation | - TWD | -Infinity% |
BRIM Biotechnology, Inc. | 108 Thousand TWD | -10894.444% |
Greenyn Biotechnology Co., Ltd | 55.91 Million TWD | 78.765% |
TaiGen Biopharmaceuticals Holdings Limited | 58.71 Million TWD | 79.775% |
Medigen Biotechnology Corp. | 449.09 Million TWD | 97.356% |
Intech Biopharm Corporation | 970.4 Million TWD | 98.776% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | 97.016% |
TCI GENE Inc. | - TWD | -Infinity% |
MegaPro Biomedical Co., Ltd | 5.62 Million TWD | -110.981% |
NatureWise Biotech & Medicals Corporation | 3.26 Million TWD | -263.675% |
PharmaEngine, Inc. | 7.14 Million TWD | -66.233% |
Savior Lifetec Corporation | 257.03 Million TWD | 95.38% |
OBI Pharma, Inc. | 439.88 Million TWD | 97.301% |
Medigen Vaccine Biologics Corporation | 254.35 Million TWD | 95.332% |
Meribank Biotech Co., Ltd | 14.81 Million TWD | 19.83% |
Acepodia, Inc. | 233.45 Million TWD | 94.914% |